Clinical Trial Update: Drug Drug Interaction Study for EYP001 With Entecavir [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study of EYP001 with Entecavir has completed. The study investigates potential interactions for chronic hepatitis B under Enyo Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• EYP001 (EYP001)

Snippet

Sponsor: Enyo Pharma | Conditions: Hepatitis B, Chronic | Phase 1 | Status: COMPLETED